The journal retracts the article, “Myogenesis Effects of RGX365 to Improve Skeletal Muscle Atrophy” [1], cited above.
Following publication, concerns were brought to the attention of the publisher regarding a number of image duplications contained within this publication [1].
Adhering to our standard procedure, an investigation was conducted by the Editorial Office and Editorial Board that confirmed the presence of duplicated panels contained within Figures 1C and 4A, presenting different experimental conditions. While the authors cooperated with the investigation, they were unable to satisfactorily explain these duplications nor were they able to provide verifiable supplementary material for evaluation by the Editorial Board. As a consequence, the Editorial Board have lost confidence in the validity of the findings and decided to retract the publication [1] as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30 (accessed on 20 September 2024)).
This retraction was approved by the Editor-in-Chief of the journal Nutrients.
The authors did not agree to this retraction.
Reference
- Lee, H.-J.; Choi, H.-J.; Lee, S.-A.; Baek, D.H.; Heo, J.B.; Song, G.Y.; Lee, W. RETRACTED: Myogenesis Effects of RGX365 to Improve Skeletal Muscle Atrophy. Nutrients 2023, 15, 4307. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).